President & Chief Executive Officer, Arcturus Therapeutics Ltd.
Joseph Payne, is the President and Chief Executive Officer of Arcturus Therapeutics Ltd. He brings with him an exceptional track record of ushering novel therapeutics to the clinic including targeted RNA medicines utilizing lipid-mediated delivery technologies.
Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto as evidenced by over 40 publications and patents, and several investigational new drug (IND) clinical candidates.
Joseph earned a Bachelor's Degree in Chemistry, magna cum laude, from Brigham Young University, a Master of Science in Synthetic Organic Chemistry from the University of Calgary and Executive Training Certification from MIT Sloan School of Management.